AAAAAA

   
Results: 1-25 | 26-50
Results: 1-25/50
IMMUNOLOGICAL RESPONSE TO THE DUAL MURINE ANTI-ID VACCINE MELIMMUNE-1AND MELIMMUNE-2 IN PATIENTS WITH HIGH-RISK MELANOMA WITHOUT EVIDENCE OF SYSTEMIC-DISEASE
Authors: SALEH MN LALISAN DY PRIDE MW SOLINGER A MAYO MS LOBUGLIO AF MURRAY JL
Citation: Mn. Saleh et al., IMMUNOLOGICAL RESPONSE TO THE DUAL MURINE ANTI-ID VACCINE MELIMMUNE-1AND MELIMMUNE-2 IN PATIENTS WITH HIGH-RISK MELANOMA WITHOUT EVIDENCE OF SYSTEMIC-DISEASE, Journal of immunotherapy, 21(5), 1998, pp. 379-388
DOSIMETRY RESULTS OF ONCOLYM(TM) IN THE TREATMENT OF REFRACTORY B-CELL NON-HODGKINS-LYMPHOMA (NHL)
Authors: VERKH LI MURRAY JL KRIPAS CJ WESSELS BW VARMA VM KAHN D BUSHNELL DL SERAFINI AN OLIVER JC
Citation: Li. Verkh et al., DOSIMETRY RESULTS OF ONCOLYM(TM) IN THE TREATMENT OF REFRACTORY B-CELL NON-HODGKINS-LYMPHOMA (NHL), CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 13(1), 1998, pp. 49-49
GROWTH AND ANTIGEN RECOGNITION OF TUMOR-INFILTRATING LYMPHOCYTES FROMHUMAN BREAST-CANCER
Authors: HUDSON JM CASTILLEJA A MURRAY JL HONDA T KUDELKA A SINGLETARY E WHARTON JT IOANNIDES CG
Citation: Jm. Hudson et al., GROWTH AND ANTIGEN RECOGNITION OF TUMOR-INFILTRATING LYMPHOCYTES FROMHUMAN BREAST-CANCER, Journal of interferon & cytokine research, 18(7), 1998, pp. 529-536
PROLIFERATIVE AND CYTOKINE RESPONSES TO CLASS-II HER-2 NEU-ASSOCIATEDPEPTIDES IN BREAST-CANCER PATIENTS/
Authors: TUTTLE TM ANDERSON BW THOMPSON WE LEE JE SAHIN A SMITH TL GRABSTEIN KH WHARTON JT IOANNIDES CG MURRAY JL
Citation: Tm. Tuttle et al., PROLIFERATIVE AND CYTOKINE RESPONSES TO CLASS-II HER-2 NEU-ASSOCIATEDPEPTIDES IN BREAST-CANCER PATIENTS/, Clinical cancer research, 4(8), 1998, pp. 2015-2024
ENHANCEMENT OF CELL-MEDIATED-IMMUNITY IN MELANOMA PATIENTS IMMUNIZED WITH MURINE ANTIIDIOTYPIC MONOCLONAL-ANTIBODIES (MELIMMUNE(R)) THAT MIMIC THE HIGH-MOLECULAR-WEIGHT PROTEOGLYCAN ANTIGEN
Authors: PRIDE MW SHUEY S GRILLOLOPEZ A BRASLAWSKY O ROSS M LEGHA SS ETON O BUZAID A IOANNIDES C MURRAY JL
Citation: Mw. Pride et al., ENHANCEMENT OF CELL-MEDIATED-IMMUNITY IN MELANOMA PATIENTS IMMUNIZED WITH MURINE ANTIIDIOTYPIC MONOCLONAL-ANTIBODIES (MELIMMUNE(R)) THAT MIMIC THE HIGH-MOLECULAR-WEIGHT PROTEOGLYCAN ANTIGEN, Clinical cancer research, 4(10), 1998, pp. 2363-2370
THE AL-HF (ALUMINUM-HAFNIUM) SYSTEM
Authors: MURRAY JL MCALISTER AJ KAHAN DJ
Citation: Jl. Murray et al., THE AL-HF (ALUMINUM-HAFNIUM) SYSTEM, Journal of phase equilibria, 19(4), 1998, pp. 376-379
THE AL-SC (ALUMINUM-SCANDIUM) SYSTEM
Authors: MURRAY JL
Citation: Jl. Murray, THE AL-SC (ALUMINUM-SCANDIUM) SYSTEM, Journal of phase equilibria, 19(4), 1998, pp. 380-384
PROFILING THE CHIEF LAW-SCHOOL PLACEMENT OFFICER - IMPLICATIONS FOR STUDENT-DEVELOPMENT SPECIALISTS IN PROFESSIONAL SCHOOL SETTINGS
Authors: MURRAY JL
Citation: Jl. Murray, PROFILING THE CHIEF LAW-SCHOOL PLACEMENT OFFICER - IMPLICATIONS FOR STUDENT-DEVELOPMENT SPECIALISTS IN PROFESSIONAL SCHOOL SETTINGS, Journal of college student development, 39(1), 1998, pp. 58-74
EFFECT OF RECOMBINANT ALPHA-INTERFERON ON PHARMACOKINETICS, BIODISTRIBUTION, TOXICITY, AND EFFICACY OF I-131-LABELED MONOCLONAL-ANTIBODY CC49 IN BREAST-CANCER - A PHASE-II TRIAL
Authors: MACEY DJ GRANT EJ KASI L ROSENBLUM MG ZHANG HZ KATZ RL RIEGER PT LEBHERZ D SOUTH M GREINER JW SCHLOM J PODOLOFF DA MURRAY JL
Citation: Dj. Macey et al., EFFECT OF RECOMBINANT ALPHA-INTERFERON ON PHARMACOKINETICS, BIODISTRIBUTION, TOXICITY, AND EFFICACY OF I-131-LABELED MONOCLONAL-ANTIBODY CC49 IN BREAST-CANCER - A PHASE-II TRIAL, Clinical cancer research, 3(9), 1997, pp. 1547-1555
RECOMBINANT INTERLEUKIN-2 IN COMBINATION WITH RECOMBINANT INTERFERON-GAMMA IN PATIENTS WITH ADVANCED MALIGNANCY - A PHASE-1 STUDY
Authors: REDDY SP HARWOOD RM MOORE DF GRIMM EA MURRAY JL VADHANRAJ S
Citation: Sp. Reddy et al., RECOMBINANT INTERLEUKIN-2 IN COMBINATION WITH RECOMBINANT INTERFERON-GAMMA IN PATIENTS WITH ADVANCED MALIGNANCY - A PHASE-1 STUDY, Journal of immunotherapy with emphasis on tumor immunology, 20(1), 1997, pp. 79-87
MASS-SPECTROMETRIC ANALYSIS OF NATURALLY PROCESSED PEPTIDES RECOGNIZED BY OVARIAN TUMOR-ASSOCIATED CD8(+) CTL
Authors: FISK B DAGUE B SEIFERT WE KUDELKA AP WHARTON JT MURRAY JL IOANNIDES CG
Citation: B. Fisk et al., MASS-SPECTROMETRIC ANALYSIS OF NATURALLY PROCESSED PEPTIDES RECOGNIZED BY OVARIAN TUMOR-ASSOCIATED CD8(+) CTL, International journal of oncology, 10(1), 1997, pp. 159-169
SELENIUM-DEPENDENT GLUTATHIONE-PEROXIDASE (SEGPX) ACTIVITY CAN ALTER THE COURSE OF A HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) INFECTION
Authors: DIAMOND AM MURRAY JL FOLKS TM SANDSTROM PA
Citation: Am. Diamond et al., SELENIUM-DEPENDENT GLUTATHIONE-PEROXIDASE (SEGPX) ACTIVITY CAN ALTER THE COURSE OF A HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) INFECTION, The FASEB journal, 11(3), 1997, pp. 1373-1373
EXISTENT PROLIFERATIVE RESPONSES OF PERIPHERAL-BLOOD MONONUCLEAR-CELLS FROM HEALTHY DONORS AND OVARIAN-CANCER PATIENTS TO HER-2 PEPTIDES
Authors: FISK B HUDSON M KAVANAGH J WHARTON JT MURRAY JL IOANNIDES CG KUDELKA AP
Citation: B. Fisk et al., EXISTENT PROLIFERATIVE RESPONSES OF PERIPHERAL-BLOOD MONONUCLEAR-CELLS FROM HEALTHY DONORS AND OVARIAN-CANCER PATIENTS TO HER-2 PEPTIDES, Anticancer research, 17(1A), 1997, pp. 45-53
HER-2 NEU PEPTIDE INDUCES TH1 RESPONSES IN ASSOCIATION WITH HLA-DR4 IN BREAST-CANCER PATIENTS/
Authors: TUTTLE TM THOMPSON WE ANDERSON BW LEE JE GRABSTEIN KW MURRAY JL WHARTON JT IOANNIDES CG
Citation: Tm. Tuttle et al., HER-2 NEU PEPTIDE INDUCES TH1 RESPONSES IN ASSOCIATION WITH HLA-DR4 IN BREAST-CANCER PATIENTS/, Journal of allergy and clinical immunology, 99(1), 1997, pp. 188-188
BLOOD-GROUP ANTIGENS RB-A, TR-A, AND WD(A) ARE LOCATED IN THE 3RD ECTOPLASMIC LOOP OF ERYTHROID BAND-3
Authors: JAROLIM P MURRAY JL RUBIN HL SMART E MOULDS JM
Citation: P. Jarolim et al., BLOOD-GROUP ANTIGENS RB-A, TR-A, AND WD(A) ARE LOCATED IN THE 3RD ECTOPLASMIC LOOP OF ERYTHROID BAND-3, Transfusion, 37(6), 1997, pp. 607-615
A THR(552)-]ILE SUBSTITUTION IN ERYTHROID BAND-3 GIVES RISE TO THE WARRIOR BLOOD-GROUP ANTIGEN
Authors: JAROLIM P MURRAY JL RUBIN HL COGHLAN G ZELINSKI T
Citation: P. Jarolim et al., A THR(552)-]ILE SUBSTITUTION IN ERYTHROID BAND-3 GIVES RISE TO THE WARRIOR BLOOD-GROUP ANTIGEN, Transfusion, 37(4), 1997, pp. 398-405
THE PROPHET AND THE WOMAN WHO SHATTERS AND HEALS
Authors: MURRAY JL
Citation: Jl. Murray, THE PROPHET AND THE WOMAN WHO SHATTERS AND HEALS, Journal of religion and health, 36(2), 1997, pp. 165-171
IDENTIFICATION OF NATURALLY PROCESSED HUMAN OVARIAN PEPTIDES RECOGNIZED BY TUMOR-ASSOCIATED CD8(-LYMPHOCYTES() CYTOTOXIC T)
Authors: FISK B ANDERSON BW GRAVITT KR OBRIAN CA KUDELKA AP MURRAY JL WHARTON JT IOANNIDES CG
Citation: B. Fisk et al., IDENTIFICATION OF NATURALLY PROCESSED HUMAN OVARIAN PEPTIDES RECOGNIZED BY TUMOR-ASSOCIATED CD8(-LYMPHOCYTES() CYTOTOXIC T), Cancer research, 57(1), 1997, pp. 87-93
PHASE-IA IB TRIAL OF ANTI-GD2 CHIMERIC MONOCLONAL-ANTIBODY-14.18 (CH14.18) AND RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (RHGM-CSF) IN METASTATIC MELANOMA/
Authors: MURRAY JL KLEINERMAN ES JIA SF ROSENBLUM MG ETON O BUZAID A LEGHA S ROSS MI THOMPSON L MUJOO K RIEGER PT SALEH M KHAZAELI MB VADHANRAJ S
Citation: Jl. Murray et al., PHASE-IA IB TRIAL OF ANTI-GD2 CHIMERIC MONOCLONAL-ANTIBODY-14.18 (CH14.18) AND RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (RHGM-CSF) IN METASTATIC MELANOMA/, Journal of immunotherapy with emphasis on tumor immunology, 19(3), 1996, pp. 206-217
LOVASTATIN EFFECTS ON HUMAN BREAST-CARCINOMA CELLS - DIFFERENTIAL TOXICITY OF AN ADRIAMYCIN-RESISTANT DERIVATIVE AND INFLUENCE ON SELENOCYSTEINE TRANSFER-RNAS
Authors: DIAMOND AM JAFFE D MURRAY JL SAFA AR SAMUELS BL HATFIELD DL
Citation: Am. Diamond et al., LOVASTATIN EFFECTS ON HUMAN BREAST-CARCINOMA CELLS - DIFFERENTIAL TOXICITY OF AN ADRIAMYCIN-RESISTANT DERIVATIVE AND INFLUENCE ON SELENOCYSTEINE TRANSFER-RNAS, Biochemistry and molecular biology international, 38(2), 1996, pp. 345-355
OVARIAN AND BREAST CYTOTOXIC LYMPHOCYTES CAN RECOGNIZE PEPTIDES FROM THE AES PROTEIN OF THE NOTCH COMPLEX
Authors: IOANNIDES CG FISK B MELICHAR B ANDERSON B STIFANI S PAPAYANNOPOULOS CG MURRAY JL KUDELKA A WHARTON JT
Citation: Cg. Ioannides et al., OVARIAN AND BREAST CYTOTOXIC LYMPHOCYTES CAN RECOGNIZE PEPTIDES FROM THE AES PROTEIN OF THE NOTCH COMPLEX, The FASEB journal, 10(6), 1996, pp. 2519-2519
CHARACTERIZATION OF ANTIGEN RECOGNITION IN TUMOR-INFILTRATING LYMPHOCYTES IN BREAST-CANCER
Authors: MELICHAR B HUDSON JM HONDA T TUTTLE T MURRAY JL WHARTON JT IOANNIDES CG
Citation: B. Melichar et al., CHARACTERIZATION OF ANTIGEN RECOGNITION IN TUMOR-INFILTRATING LYMPHOCYTES IN BREAST-CANCER, The FASEB journal, 10(6), 1996, pp. 2713-2713
CELLULAR-RESISTANCE TO THE ANTIMELANOMA IMMUNOTOXIN ZME-GELONIN AND STRATEGIES TO TARGET RESISTANT CELLS
Authors: ROSENBLUM MG CHEUNG L KIM SK MUJOO K DONATO NJ MURRAY JL
Citation: Mg. Rosenblum et al., CELLULAR-RESISTANCE TO THE ANTIMELANOMA IMMUNOTOXIN ZME-GELONIN AND STRATEGIES TO TARGET RESISTANT CELLS, Cancer immunology and immunotherapy, 42(2), 1996, pp. 115-121
TC-99(M)-IMMU4 IMAGING IN RECURRENT COLORECTAL-CANCER - EFFICACY AND IMPACT ON SURGICAL-MANAGEMENT
Authors: SIRISRIRO R PODOLOFF DA PATT YZ CURLEY SA KASI LP BHADKAMKAR VA KIM EE MURRAY JL SMITH R HAYNIE TP
Citation: R. Sirisriro et al., TC-99(M)-IMMU4 IMAGING IN RECURRENT COLORECTAL-CANCER - EFFICACY AND IMPACT ON SURGICAL-MANAGEMENT, Nuclear medicine communications, 17(7), 1996, pp. 568-576
A THR(552)-]ILE SUBSTITUTION IN ERYTHROID BAND-3 GIVES RISE TO THE WARRIOR BLOOD-GROUP ANTIGEN
Authors: JAROLIM P MURRAY JL RUBIN HL COGHLAN G ZELINSKI T
Citation: P. Jarolim et al., A THR(552)-]ILE SUBSTITUTION IN ERYTHROID BAND-3 GIVES RISE TO THE WARRIOR BLOOD-GROUP ANTIGEN, Transfusion, 36(9), 1996, pp. 193-193
Risultati: 1-25 | 26-50